@article {Ioanas876, author = {Ioanas, M. and Cavalcanti, M. and Ferrer, M. and Valencia, M. and Agusti, C. and Puig de la Bellacasa, J. and Torres, A.}， title ={医院获得性肺炎:}， volume = {22}， number = {6}， pages ={876—882}，year = {2003}， doi = {10.1183/09031936.03.00045903}， publisher ={欧洲呼吸学会}，188bet官网地址1996年美国胸科学会(ATS)发布的医院获得性肺炎(HAP)指南和1998年发布的Trouillet分类为HAP患者的分类和初始抗生素治疗的选择提供了不同的合理依据。本研究的目的是评估细菌覆盖水平，并评估和验证每种分类的抗生素策略的充分性。对71例怀疑有HAP的重症监护室患者进行评估。ATS和Trouillet分类对病原微生物的预测准确率分别为91%和83%。ATS和Trouillet抗生素治疗建议分别适用于79%和80%的患者。ATS指南治疗不当涉及的微生物有铜绿假单胞菌(n=3)、鲍曼不动杆菌(n=1)、嗜麦芽窄养单胞菌(n=1)和耐甲氧西林金黄色葡萄球菌(n=1)。铜绿假单胞菌与trouilet治疗不充分有关。目前对医院获得性肺炎(美国胸科学会和Trouillet)经验抗生素治疗的建议显示了良好的预测相关病原体的能力。 However, considering the resistance pattern of the isolated pathogens, both classifications demonstrated a rather lower treatment adequacy; the main reason was the failure to treat highly resistant strains. M. Ioanas was a recipient of a European Respiratory Society Research Fellowship in 2000, M. Cavalcanti in 2003 and M. Valencia in 2002. The study was supported by Red Gira and Red Respira.}, issn = {0903-1936}, URL = {//www.qdcxjkg.com/content/22/6/876}, eprint = {//www.qdcxjkg.com/content/22/6/876.full.pdf}, journal = {European Respiratory Journal} }